Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Freelancers learn how to determine an appropriate emergency fund length given variable workloads, invoicing cycles, and income gaps.
22,516 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
The Bank of England's top regulator raises alarms about dollar-pegged tokens and oversight gaps, foreshadowing a tens...
A quiet-upstart tech company just got upgraded by analysts after solid earnings. This under-the-radar growth stock ma...
Bank of America raises NVIDIA's price target to $320, backing the move with a brighter view of a $1.7 trillion AI dat...
Rocket Lab is expanding by purchasing a competing space systems group for up to $60 million. This article breaks down...
A clear, practical breakdown of DEFT's Q4 2025 results and what the deft 2025 earnings transcript signals for 2026. L...
A small AI stock makes a big move. SoundHound AI just released a pivotal update that could affect its 2027 outlook an...
AI-driven forecasts for XRP and Solana diverge by end-2026, leaving investors weighing who could win. The analysis us...
ThredUp's chief argues that a permanent four-day workweek provides a competitive edge in attracting talent. The broad...
The nuclear energy sector is staging a comeback. This article breaks down two top stock ideas, explains why they matt...
As of May 2026, millions of U.S. households still pay only the minimum on credit cards, leaving balances alive for ye...
Wall Street’s bearish take on Plug Power stock has critics unsure. This article builds a practical bull case, showing...